These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 36255682)

  • 81. GM1 ganglioside in the treatment of Parkinson's disease.
    Schneider JS
    Ann N Y Acad Sci; 1998 Jun; 845():363-73. PubMed ID: 9668369
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Oriented 1,2-dimyristoyl-sn-glycero-3-phosphorylcholine/ganglioside membranes: a Fourier transform infrared attenuated total reflection spectroscopic study. Band assignments; orientational, hydrational, and phase behavior; and effects of Ca2+ binding.
    Müller E; Giehl A; Schwarzmann G; Sandhoff K; Blume A
    Biophys J; 1996 Sep; 71(3):1400-21. PubMed ID: 8874015
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Soluble Aβ oligomers are rapidly sequestered from brain ISF in vivo and bind GM1 ganglioside on cellular membranes.
    Hong S; Ostaszewski BL; Yang T; O'Malley TT; Jin M; Yanagisawa K; Li S; Bartels T; Selkoe DJ
    Neuron; 2014 Apr; 82(2):308-19. PubMed ID: 24685176
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.
    Ariga T; McDonald MP; Yu RK
    J Lipid Res; 2008 Jun; 49(6):1157-75. PubMed ID: 18334715
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Developmental changes of gangliosides of the rat stomach. Appearance of a blood group B-active ganglioside.
    Bouhours JF; Bouhours D; Hansson GC
    J Biol Chem; 1987 Dec; 262(34):16370-5. PubMed ID: 3680254
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Turning the spotlight on the oligosaccharide chain of GM1 ganglioside.
    Chiricozzi E; Di Biase E; Lunghi G; Fazzari M; Loberto N; Aureli M; Mauri L; Sonnino S
    Glycoconj J; 2021 Feb; 38(1):101-117. PubMed ID: 33620588
    [TBL] [Abstract][Full Text] [Related]  

  • 87. GM1 / GD1b / GA1 synthase expression results in the reduced cancer phenotypes with modulation of composition and raft-localization of gangliosides in a melanoma cell line.
    Dong Y; Ikeda K; Hamamura K; Zhang Q; Kondo Y; Matsumoto Y; Ohmi Y; Yamauchi Y; Furukawa K; Taguchi R; Furukawa K
    Cancer Sci; 2010 Sep; 101(9):2039-47. PubMed ID: 20594196
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The sialic acid residue of exogenous GM1 ganglioside is recycled for biosynthesis of sialoglycoconjugates in rat liver.
    Ghidoni R; Trinchera M; Sonnino S; Chigorno V; Tettamanti G
    Biochem J; 1987 Oct; 247(1):157-64. PubMed ID: 3689344
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A radioassay for GM1 ganglioside concentration in cerebrospinal fluid.
    Ginns E; French J
    J Neurochem; 1980 Oct; 35(4):977-82. PubMed ID: 7005403
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Ganglioside GM1 Targets Astrocytes to Stimulate Cerebral Energy Metabolism.
    Finsterwald C; Dias S; Magistretti PJ; Lengacher S
    Front Pharmacol; 2021; 12():653842. PubMed ID: 33995070
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Identification and localization of the GM1 ganglioside in the cochlea using thin-layer chromatography and cholera toxin.
    Santi PA; Mancini P; Barnes C
    J Histochem Cytochem; 1994 Jun; 42(6):705-16. PubMed ID: 8189033
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review.
    Zhang W; Krafft PR; Wang T; Zhang JH; Li L; Tang J
    Cell Transplant; 2019 Jun; 28(6):657-661. PubMed ID: 30666888
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Gangliosides of liver tumors induced by N-2-fluorenylacetamide. I. Ganglioside alterations in liver tumorigenesis and normal development.
    Merritt WD; Richardson CL; Keenan TW; Morré DJ
    J Natl Cancer Inst; 1978 Jun; 60(6):1313-27. PubMed ID: 206706
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Dot-blot immunodetection of antibodies against GM1 and other gangliosides on PVDF-P membranes.
    Chabraoui F; Derrington EA; Mallie-Didier F; Confavreux C; Quincy C; Caudie C
    J Immunol Methods; 1993 Oct; 165(2):225-30. PubMed ID: 8228272
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Role of gangliosides in Alzheimer's disease.
    Yanagisawa K
    Biochim Biophys Acta; 2007 Aug; 1768(8):1943-51. PubMed ID: 17321494
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Cortical distribution of gangliosides in Alzheimer's disease.
    Kracun I; Kalanj S; Talan-Hranilovic J; Cosovic C
    Neurochem Int; 1992 Apr; 20(3):433-8. PubMed ID: 1304338
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Binding of choleragen and anti-ganglioside antibodies to gangliosides incorporated into preformed liposomes.
    Richards RL; Fishman PH; Moss J; Alving CR
    Biochim Biophys Acta; 1983 Sep; 733(2):249-55. PubMed ID: 6882761
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Inheritance of lysosomal acid beta-galactosidase activity and gangliosides in crosses of DBA/2J and knockout mice.
    Hauser EC; Kasperzyk JL; d'Azzo A; Seyfried TN
    Biochem Genet; 2004 Aug; 42(7-8):241-57. PubMed ID: 15487588
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Process Engineering and Glycosyltransferase Improvement for Short Route Chemoenzymatic Total Synthesis of GM1 Gangliosides.
    Yu H; Zhang L; Yang X; Bai Y; Chen X
    Chemistry; 2023 May; 29(25):e202300005. PubMed ID: 36596720
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The relationship between depletion of brain GM1 ganglioside and Parkinson's disease.
    Sonnino S
    FEBS Open Bio; 2023 Sep; 13(9):1548-1557. PubMed ID: 36638010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.